nach oben

Erschienen in:

22.08.2022 | Apoplex | Zertifizierte Fortbildung Neurologie

Verengung hirnversorgender Gefäße

Management der extrakraniellen Karotisstenose

verfasst von: Prof. Dr. med. Hans-Christoph Diener, Prof. Dr. med. Christian Gerloff, Prof. Dr. med. Jens Fiehler, Univ.-Prof. Dr. med. Hans-Henning Eckstein

Erschienen in: InFo Neurologie + Psychiatrie | Ausgabe 7-8/2022

Einloggen, um Zugang zu erhalten

Auszug

Atherosklerotisch bedingte Stenosen der Arteria carotis interna sind für 8-15 % aller ischämischen Schlaganfälle verantwortlich. Die Karotisendarteriektomie hat bei mittel- bis höhergradigen symptomatischen Karotisstenosen ihre Überlegenheit gegenüber einer rein konservativen Therapie belegt. Bei Vorliegen einer höhergradigen symptomatischen Karotisstenose soll frühzeitig eine Karotisendarteriektomie durchgeführt werden. Bei Patienten unter 70 Jahren mit einer symptomatischen 50-99 %igen Karotisstenose kann ein Karotisstenting in Betracht gezogen werden. Abgesehen von den verfahrensbedingten Komplikationen sind beide Behandlungen mittel- bis langfristig gleich wirksam bei der Prävention von Schlaganfällen. …

Amarenco P, Lavallee PC, Labreuche J et al. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. N Engl J Med. 2016;374(16):1533-42

Song P, Fang Z, Wang H et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8(5):e721-e9

Bonati LH, Jansen O, de Borst GJ et al. Management of atherosclerotic extracranial carotid artery stenosis. Lancet Neurol. 2022;21(3):273-83

Eckstein H-H, Kühnl A, Berkefeld J, Lawall H, Storck M, Sander D. Diagnostik, Therapie und Nachsorge der extrakraniellen Karotisstenose. Dtsch Arztebl International. 2020;117(47):801-7

Bonati LH, Kakkos S, Berkefeld J et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. European Stroke Journal. 2021;6(2):I-XLVII

Naylor AR, Rantner B, Ancetti S, de Borst GJ et al. European society for vascular surgery (ESVS) 2023 Clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. Eur J Vasc Endovasc Surg. 2022

Murphy SJX, Naylor AR, Ricco JB, Sillesen H, Kakkos S, Halliday A, et al. Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature. Eur J Vasc Endovasc Surg. 2019;57(2):199-211

Anand SS, Bosch J, Eikelboom JW et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):219-29

Johnston SC et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018;379(3):215-25

10.

Wang Y, Wang Y, Zhao X et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11-9

11.

Johnston SC, Amarenco P, Denison H et al. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N Engl J Med. 2020;383(3):207-17

12.

Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339:1415-25

13.

European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-87

14.

Rothwell PM et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361(9352):107-16

15.

Mas JL et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355(16):1660-71

16.

Ringleb PA, Allenberg J, Bruckmann H et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006;368(9543):1239-47

17.

Eckstein HH, Ringleb P, Allenberg JR et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7(10):893-902

18.

Ederle J, Dobson J, Featherstone RL et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375(9719):985-97

19.

Brott TG et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11-23

20.

Muller MD, Lyrer P, Brown MM, Bonati LH. Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Cochrane Database Syst Rev. 2020;2:CD000515

21.

Halliday A, Mansfield A, Marro J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363:1491-502

22.

Rosenfield K, Matsumura JS, Chaturvedi S et al. Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis. N Engl J Med. 2016;374(11):1011-20

23.

Halliday A, Bulbulia R, Bonati LHet al. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet. 2021;398(10305):1065-73

24.

Jansen O, Fiehler J, Hartmann M, Bruckmann H. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial. Stroke. 2009;40(3):841-6

25.

Vanzin JR, de Castro-Afonso LH, Santos MN, Manzato LB, Nakiri GS, Monsignore LM, et al. Casper vs. Closed-Cell Stent : Carotid Artery Stenting Randomized Trial. Clin Neuroradiol. 2021;31(3):843-52

26.

Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358(15):1572-9

27.

Bonati LH, Gregson J, Dobson J et al. Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial. Lancet Neurol. 2018;17(7):587-96

28.

Barkat M, Hajibandeh S, Hajibandeh S, Torella F, Antoniou GA. Systematic Review and Meta-analysis of Dual Versus Single Antiplatelet Therapy in Carotid Interventions. Eur J Vasc Endovasc Surg. 2017;53(1):53-67

29.

de Borst GJ et al. Operative management of carotid artery in-stent restenosis: first experiences and duplex follow-up. Eur J Vasc Endovasc Surg. 2003;26(2):137-40

30.

Mas JL, Chatellier G, Beyssen B et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355(16):1660-71

31.

Huibers A, Halliday A, Bulbulia R et al. Antiplatelet Therapy in Carotid Artery Stenting and Carotid Endarterectomy in the Asymptomatic Carotid Surgery Trial-2. Eur J Vasc Endovasc Surg. 2016;51(3):336-42

32.

Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report. Catheter Cardiovasc Interv. 2013;81(1):E76-123

33.

Muller-Schunk S, Linn J, Peters N, Spannagl M et al. Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting. AJNR Am J Neuroradiol. 2008;29(4):786-91 Shim EJ, Ryu CW, Park S, Lee HN, Shin HS, Kim SB. Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis. J Neurointerv Surg. 2018;10(10):942-8

34.

Bonati LH, Dobson J, Featherstone RL et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet. 2015;385(9967):529-38

35.

Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W, et al. Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. N Engl J Med. 2016;374(11):1021-31

36.

Brott TG, Calvet D, Howard G et al. Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data. Lancet Neurol. 2019;18(4):348-56

37.

Müller MD, Lyrer P, Brown MM, Bonati LH. Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Cochrane Database Syst Rev. 2020;2(2):Cd000515

38.

Kumar R, Batchelder A, Saratzis A et al. Restenosis after Carotid Interventions and Its Relationship with Recurrent Ipsilateral Stroke: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2017;53(6):766-75

39.

Weimar C, Bilbilis K, Rekowski Jet al. Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting: A Randomized Clinical Trial. Stroke. 2017;48(10):2769-75

Titel: Verengung hirnversorgender Gefäße
Management der extrakraniellen Karotisstenose
verfasst von: Prof. Dr. med. Hans-Christoph Diener
Prof. Dr. med. Christian Gerloff
Prof. Dr. med. Jens Fiehler
Univ.-Prof. Dr. med. Hans-Henning Eckstein
Publikationsdatum: 22.08.2022
Verlag: Springer Medizin
Schlagwörter: Apoplex
Acetylsalicylsäure
Acetylsalicylsäure
Karotisstenose
Karotisstenose
Erschienen in: InFo Neurologie + Psychiatrie / Ausgabe 7-8/2022
Print ISSN: 1437-062X
Elektronische ISSN: 2195-5166
DOI: https://doi.org/10.1007/s15005-022-2438-6

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7-8/2022

Tenecteplase in der MSU von Vorteil

Nutzt Methylphenidat auch langfristig?

Schneller zur richtigen Diagnose

Nutzen der frühzeitigen Behandlung mit Ofatumumab bestätigt

Behandlung von Agitation bei Demenz

Ein "new kid on the block" unter den Antikörpern